“…To generate wild-type and mutant pEGFP-HIF-1α-575-826 forms, cDNA was obtained by PCR using the corresponding pEGFP-HIF-1α forms as a template, and sub-cloned as BamHI fragments into pEGFP-C1. The following antibodies were used: affinity-purified rabbit polyclonal antibody against HIF-1α (1:1000; Lyberopoulou et al, 2007); rabbit polyclonal antibodies against mortalin (sc-13967, 1:1000 dilution), TOM20 (sc-11415, 1:1000 dilution) and Gal4-DBD (sc-577, 1:500 dilution), mouse monoclonal antibody against C-terminus of PARP-1 (sc-8007, 1:5000 dilution) or goat polyclonal antibody against VDAC1 (sc-8828, 1:500 dilution) all from Santa Cruz Biotechnology (Dallas, TX); rabbit polyclonal antibodies against phospho-ERK1/2 (9101, 1:1000 dilution), ERK1/2 (9102, 1:1000 dilution), HSP60 (4870, 1:1000 dilution), caspase 3 (9662, 1:1000 dilution) and cytochrome c (4272, 1:500 dilution), rabbit monoclonal antibodies against HK-II (6867, 1:1000 dilution) and cleaved caspase-3 (9664, 1:500 dilution) and mouse monoclonal antibody against actin (3700, 1:5000 dilution) all from Cell Signaling (Danvers, MA); mouse monoclonal antibodies against HIF-1α (610959, 1:1000 dilution), ARNT (611079, 1:500 dilution) and phosphoserine (612547, 1:1000 dilution) from BD Biosciences (San Jose, CA); mouse monoclonal antibody against the Nterminus of PARP-1 (ALX-804-211, 1:5000 dilution) from Enzo Life Sciences (Farmingdale, NY); and rabbit polyclonal antibody against HIF-2α (ΝΒ100-122, 1:1000 dilution) from Novus Europe (Cambridge, UK) or against Flag (F4042, 1:10,000 dilution) from Sigma-Aldrich (St Louis, MO). Immunoblotting was performed as previously described (Mylonis et al, 2006).…”